Stocks · Health care · Pharmaceutical Preparations

Biohaven Ltd.

BHVN Clue Score30
United States Fiscal year ends December CIK 0001935979 Results filed 29 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
George C. Clark
17 Nov 2025
VP, Chief Accounting Officer
Buy indirect
17,000
$8.52
$144.77K
Vlad Coric
13 Nov 2025
Chief Executive Officer
Buy indirect
333,333
$7.50
$2.50M
Vlad Coric
13 Nov 2025
Chief Executive Officer
Buy indirect
333,333
$7.50
$2.50M
John W Childs
13 Nov 2025
Director
Buy indirect
3,333,333
$7.50
$25.00M
Gregory Bailey
13 Nov 2025
Director
Buy
400,000
$7.50
$3.00M

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 79,662
History held since 5 Oct 2022